MLBIO Stock Overview
Nortem BioGroup manufactures and markets natural products based on organic and biodegradable substances in Italy.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nortem BioGroup Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.40 |
| 52 Week High | €5.40 |
| 52 Week Low | €5.40 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLBIO | FR Personal Products | FR Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | -1.5% |
| 1Y | n/a | -0.9% | 3.4% |
Return vs Industry: Insufficient data to determine how MLBIO performed against the French Personal Products industry.
Return vs Market: Insufficient data to determine how MLBIO performed against the French Market.
Price Volatility
| MLBIO volatility | |
|---|---|
| MLBIO Average Weekly Movement | 0% |
| Personal Products Industry Average Movement | 4.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: MLBIO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MLBIO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | nortembiogroup.com |
Nortem BioGroup manufactures and markets natural products based on organic and biodegradable substances in Italy. The company provides food grade citric acid and sodium bicarbonate; Epson and Himalayan salt; spices, such as organic turmeric, ginger, and black pepper powder; and organic cocoa powder. It also offers vitamins, such as omega 3 and vitamin E food supplements, vitamin B12 food supplements, zinc and magnesium food supplements, vitamin D3 and K2 food supplements, vitamin C (ascorbic acid) powder, vitamin C (sodium ascorbate) powder, and N-acetyl cysteine food supplements.
Nortem BioGroup Fundamentals Summary
| MLBIO fundamental statistics | |
|---|---|
| Market cap | €13.92m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MLBIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLBIO income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MLBIO perform over the long term?
See historical performance and comparison